A Dutch clinical-stage biotech company
InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation drug delivery
Total raised: $32.917367M
Investors 2
| Date | Name | Website |
| - | Waterman V... | watermanve... |
| - | Aurora Sci... | aurorascie... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 09.02.2021 | Series B | $22.417367... | - | finsmes.co... |
| 15.12.2015 | Series A | $10.5M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 15.02.2021 | OostNL backs the €18.5M Series B funding round of this Dutch... | Netherlands-based InteRNA Technologies, a biopharma company that develops microRNA (miRNA)-based the... | siliconcan... |
| 09.02.2021 | InteRNA Technologies Extends Series B Financing Round Totali... | InteRNA Technologies, an Utrecht, The Netherlands-based company that designs new therapies tackling ... | finsmes.co... |
| 15.12.2015 | InteRNA Technologies Closes US$10.5M Series A Funding | InteRNA Technologies B.V., a Nijmegen, the Netherlands–based biopharma company engaged in the develo... | finsmes.co... |
| 26.03.2013 | InteRNA Technologies Raises Funding | InteRNA Technologies B.V., a Nijmegen, The Netherlands-based biopharmaceutical company, closed an eq... | finsmes.co... |